Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 158
rmMANF prevents sepsis-associated lung injury via inhibiting endoplasmic reticulum stress-induced ferroptosis in mice
Tao Zeng, Yan Zhou, Yang Yu, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109608-109608
Open Access | Times Cited: 43
Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
Lu Liu, Ling Zhou, Lingling Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 2727-2754
Open Access | Times Cited: 35
Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy
Li Yu, Ke Huang, Yixiang Liao, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 13
A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022
Yandong Miao, Wuxia Quan, Xin Dong, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs
Qi Zhang, Xinfeng Fan, Xinyu Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Crosstalk among mitophagy, pyroptosis, ferroptosis, and necroptosis in central nervous system injuries
Li Zhang, Zhigang Hu, Zhenxing Li, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1660-1670
Open Access | Times Cited: 17
HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation
Yanyan Wang, Shanfeng Wang, Wenjuan Zhang
Cell Cycle (2023) Vol. 22, Iss. 9, pp. 1116-1126
Open Access | Times Cited: 16
A novel TCGA-validated programmed cell-death-related signature of ovarian cancer
Xintong Cai, Jie Lin, Liu L, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
FeSA‐Ir/Metallene Nanozymes Induce Sequential Ferroptosis‐Pyroptosis for Multi‐Immunogenic Responses Against Lung Metastasis
Baochan Yang, Lingzhi Cao, Kun Ge, et al.
Small (2024)
Closed Access | Times Cited: 5
Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study
Lele Ye, Chunhao Long, Binbing Xu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
FTO triggers NLRP3/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer
Fubin Zhang, Tianhong Zhu, Lei Gan, et al.
Cellular Signalling (2025), pp. 111698-111698
Closed Access
Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies
Dandan Guo, Songhua Cai, Lvdan Deng, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Melatonin as a treatment for atherosclerosis: focus on programmed cell death, inflammation and oxidative stress
Reza Asemi, Elham Omidi Najafabadi, Zahra Gholami Mahmoudian, et al.
Journal of Cardiothoracic Surgery (2025) Vol. 20, Iss. 1
Open Access
Engineering materials for pyroptosis induction in cancer treatment
Jiayi Liu, Taili Chen, XianLing Liu, et al.
Bioactive Materials (2023) Vol. 33, pp. 30-45
Open Access | Times Cited: 12
Lysosome-targeted ruthenium(II) complex encapsulated with pluronic® F-127 induces oncosis in A549 cells
Nan-Lian Pan, Yuqing Zhang, Min-Ying Huang, et al.
JBIC Journal of Biological Inorganic Chemistry (2024) Vol. 29, Iss. 2, pp. 265-278
Closed Access | Times Cited: 4
Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
Wei Tan, Fangfang Dai, Qinyu Ci, et al.
BMC Women s Health (2025) Vol. 25, Iss. 1
Open Access
Research Advances in Ferroptosis in Ovarian Cancer: From Mechanism to Therapy
柳青 张
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 2394-2404
Closed Access
Exploration of pyroptosis-associated prognostic gene signature and lncRNA regulatory network in ovarian cancer
Beilei Zhang, Zhanghang Li, Kunqin Wang, et al.
Computers in Biology and Medicine (2023) Vol. 164, pp. 107343-107343
Closed Access | Times Cited: 10
FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer
Gendi Song, Zhengwei Sun, Man Chu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design
Meihong Zhang, Mengqin Guo, Yue Gao, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 7, pp. 100960-100960
Open Access | Times Cited: 3
Identification and validation of immunity- and disulfidptosis-related genes signature for predicting prognosis in ovarian cancer
Miaojia Jin, Dan Ni, Jianshu Cai, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32273-e32273
Open Access | Times Cited: 3
Targeting Ferroptosis as an Advance Strategy in Cancer Therapy
Tobias Achu Muluh, Qianqian Fu, Xiaojiao Ai, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 10-12, pp. 616-636
Closed Access | Times Cited: 3
A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer
Hiroshi Kobayashi, Chiharu Yoshimoto, Sho Matsubara, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 3, pp. 547-66
Open Access | Times Cited: 8
Effects of toxicants on endoplasmic reticulum stress and hepatic cell fate determination
Jihoon Tak, Sang Geon Kim
Toxicological Research (2023) Vol. 39, Iss. 4, pp. 533-547
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top